NASDAQ : DMAC
DiaMedica Therapeutics Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 9.52 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 513.37M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 9.95M | 9.78M | 7.62M | 8.16M | 6.16M | 4.88M |
| Research & Development | 29.28M | 24.61M | 19.06M | 13.11M | 7.84M | 8.77M |
| Operating Expenses | 39.23M | 34.40M | 26.68M | 21.27M | 14.00M | 13.65M |
| Operating Income | -39.23M | -34.40M | -26.68M | -21.27M | -14.00M | -13.65M |
| Interest & Investment Income | 1.72M | 1.66M | 2.27M | 1.93M | 353.00K | |
| Other Non Operating Income (Expenses) | 82.00K | |||||
| EBT Excluding Unusual Items | -37.51M | -32.74M | -24.41M | -19.34M | -13.65M | -13.56M |
| Pretax Income | -37.51M | -32.74M | -24.41M | -19.34M | -13.65M | -13.56M |
| Income Tax Expense | 30.00K | 28.00K | 30.00K | 43.00K | 28.00K | 28.00K |
| Net Income | -37.54M | -32.77M | -24.44M | -19.38M | -13.68M | -13.59M |
| Net Income to Common | -37.54M | -32.77M | -24.44M | -19.38M | -13.68M | -13.59M |
| Shares Outstanding (Basic) | 52.45M | 46.98M | 40.40M | 32.57M | 26.44M | 20.77M |
| Shares Outstanding (Diluted) | 52.45M | 46.98M | 40.40M | 32.57M | 26.44M | 20.77M |
| EPS (Basic) | -0.72 | -0.70 | -0.60 | -0.60 | -0.52 | -0.65 |
| EPS (Diluted) | -0.72 | -0.70 | -0.60 | -0.60 | -0.52 | -0.65 |
| Free Cash Flow | -31.54M | -29.10M | -22.10M | -18.75M | -11.59M | -12.27M |
| Free Cash Flow Per Share | -0.60 | -0.62 | -0.55 | -0.58 | -0.44 | -0.59 |
| EBITDA | -39.17M | -34.35M | -26.64M | -21.24M | -13.98M | -13.62M |
| D&A For EBITDA | 52.00K | 43.00K | 39.00K | 30.00K | 25.00K | 24.00K |
| EBIT | -39.23M | -34.40M | -26.68M | -21.27M | -14.00M | -13.65M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 5.13M | 15.65M | 3.02M | 4.54M | 4.73M | 4.71M |
| Short-Term Investments | 38.38M | 44.24M | 41.12M | 48.35M | 28.77M | 40.41M |
| Cash & Short-Term Investments | 43.50M | 59.89M | 44.15M | 52.90M | 33.50M | 45.11M |
| Other Receivables | 244.00K | 258.00K | 236.00K | 369.00K | 82.00K | 130.00K |
| Receivables | 244.00K | 258.00K | 236.00K | 369.00K | 82.00K | 130.00K |
| Prepaid Expenses | 567.00K | 481.00K | 227.00K | 411.00K | 209.00K | 84.00K |
| Other Current Assets | 42.00K | 113.00K | ||||
| Total Current Assets | 44.31M | 60.63M | 44.61M | 53.67M | 33.84M | 45.44M |
| Property, Plant & Equipment | 286.00K | 342.00K | 427.00K | 485.00K | 560.00K | 112.00K |
| Long-Term Deferred Charges | 400.00K | 400.00K | ||||
| Other Long-Term Assets | 1.31M | |||||
| Total Assets | 45.00M | 61.37M | 46.34M | 54.16M | 34.40M | 45.55M |
| Accounts Payable | 2.81M | 1.48M | 940.00K | 926.00K | 734.00K | 509.00K |
| Accrued Expenses | 3.67M | 3.54M | 4.35M | 1.78M | 1.36M | 966.00K |
| Current Portion of Leases | 116.00K | 112.00K | 103.00K | 83.00K | 69.00K | 49.00K |
| Total Current Liabilities | 6.59M | 5.13M | 5.39M | 2.79M | 2.17M | 1.52M |
| Long-Term Leases | 69.00K | 128.00K | 237.00K | 317.00K | 400.00K | 3.00K |
| Total Liabilities | 6.66M | 5.26M | 5.63M | 3.10M | 2.57M | 1.53M |
| Additional Paid-In Capital | 231.32M | 228.83M | 180.70M | 166.61M | 128.08M | 126.58M |
| Retained Earnings | -192.95M | -172.77M | -140.00M | -115.56M | -96.18M | -82.50M |
| Comprehensive Income & Other | -37.00K | 50.00K | 23.00K | 6.00K | -74.00K | -51.00K |
| Shareholders' Equity | 38.34M | 56.11M | 40.72M | 51.06M | 31.83M | 44.02M |
| Total Liabilities & Equity | 45.00M | 61.37M | 46.34M | 54.16M | 34.40M | 45.55M |
| Total Debt | 185.00K | 240.00K | 340.00K | 400.00K | 469.00K | 52.00K |
| Net Cash (Debt) | 43.32M | 59.65M | 43.81M | 52.49M | 33.03M | 45.06M |
| Net Cash Per Share | 0.83 | 1.27 | 1.08 | 1.61 | 1.25 | 2.17 |
| Filing Date Shares Outstanding | 53.93M | 53.88M | 42.86M | 37.96M | 26.46M | 26.44M |
| Total Common Shares Outstanding | 53.93M | 53.74M | 42.82M | 37.96M | 26.44M | 26.44M |
| Working Capital | 37.72M | 55.50M | 39.22M | 50.89M | 31.67M | 43.91M |
| Book Value Per Share | 0.71 | 1.04 | 0.95 | 1.35 | 1.20 | 1.66 |
| Tangible Book Value | 38.34M | 56.11M | 40.72M | 51.06M | 31.83M | 44.02M |
| Tangible Book Value Per Share | 0.71 | 1.04 | 0.95 | 1.35 | 1.20 | 1.66 |
| Machinery | 281.00K | 279.00K | 246.00K | 215.00K | 200.00K | 136.00K |
| Leasehold Improvements | 16.00K | 16.00K | 16.00K | 16.00K | 16.00K | 1.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -37.54M | -32.77M | -24.44M | -19.38M | -13.68M | -13.59M |
| Depreciation & Amortization | 52.00K | 43.00K | 39.00K | 30.00K | 25.00K | 24.00K |
| Loss (Gain) From Sale of Investments | -860.00K | -942.00K | -1.34M | -1.22M | -11.00K | 161.00K |
| Stock-Based Compensation | 4.15M | 3.85M | 2.08M | 1.68M | 1.50M | 1.56M |
| Other Operating Activities | 86.00K | 82.00K | 75.00K | 70.00K | 64.00K | 58.00K |
| Change in Accounts Receivable | -83.00K | -22.00K | 133.00K | -287.00K | 48.00K | 210.00K |
| Change in Accounts Payable | 1.55M | 535.00K | 14.00K | 192.00K | 225.00K | -590.00K |
| Change in Other Net Operating Assets | 1.14M | 162.00K | 1.36M | 188.00K | 312.00K | -81.00K |
| Operating Cash Flow | -31.51M | -29.06M | -22.08M | -18.73M | -11.51M | -12.25M |
| Capital Expenditures | -33.00K | -40.00K | -25.00K | -24.00K | -81.00K | -22.00K |
| Sale of Property, Plant & Equipment | 2.00K | |||||
| Investment in Securities | -11.61M | -2.15M | 8.59M | -18.27M | 11.62M | -20.52M |
| Investing Cash Flow | -11.64M | -2.19M | 8.56M | -18.30M | 11.54M | -20.54M |
| Long-Term Debt Repaid | -10.00K | -9.00K | -6.00K | -6.00K | -6.00K | |
| Net Debt Issued (Repaid) | -11.00K | -10.00K | -9.00K | -6.00K | -6.00K | -6.00K |
| Issuance of Common Stock | 44.58M | 44.29M | 12.00M | 36.85M | 30.24M | |
| Other Financing Activities | -400.00K | -400.00K | -151.00K | |||
| Financing Cash Flow | 44.17M | 43.88M | 11.99M | 36.84M | -6.00K | 30.09M |
| Net Cash Flow | 1.02M | 12.62M | -1.52M | -185.00K | 21.00K | -2.70M |
| Free Cash Flow | -31.54M | -29.10M | -22.10M | -18.75M | -11.59M | -12.27M |
| Free Cash Flow Per Share | -0.60 | -0.62 | -0.55 | -0.58 | -0.44 | -0.59 |
| Levered Free Cash Flow | -17.65M | -18.19M | -11.68M | -11.45M | -6.69M | -7.37M |
| Unlevered Free Cash Flow | -17.65M | -18.19M | -11.68M | -11.45M | -6.69M | -7.37M |
| Cash Income Tax Paid | 29.00K | 28.00K | 26.00K | 33.00K | 27.00K | 28.00K |
| Change in Working Capital | 2.60M | 675.00K | 1.51M | 93.00K | 585.00K | -461.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 501.51M | 414.54M | 232.19M | 107.79M | 41.78M | 98.62M |
| Enterprise Value | 458.19M | 359.48M | 182.36M | 52.00M | 6.16M | 50.59M |
| Last Close Price | 9.25 | 7.96 | 5.43 | 2.84 | 1.58 | 3.73 |
| PB Ratio | 13.01 | 7.39 | 5.70 | 2.11 | 1.31 | 2.24 |
| P/TBV Ratio | 13.18 | 7.39 | 5.70 | 2.11 | 1.31 | 2.24 |
| Debt / Equity Ratio | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 |
| Net Debt / Equity Ratio | -1.13 | -1.06 | -1.08 | -1.03 | -1.04 | -1.02 |
| Net Debt / EBITDA Ratio | 1.11 | 1.74 | 1.64 | 2.47 | 2.36 | 3.31 |
| Net Debt / FCF Ratio | 1.37 | 2.05 | 1.98 | 2.80 | 2.85 | 3.67 |
| Quick Ratio | 6.63 | 11.72 | 8.23 | 19.12 | 15.49 | 29.69 |
| Current Ratio | 6.72 | 11.81 | 8.28 | 19.27 | 15.61 | 29.82 |
| Return on Equity (ROE) | -114.61% | -67.68% | -53.27% | -46.77% | -36.06% | -38.81% |
| Return on Assets (ROA) | -64.12% | -39.92% | -33.18% | -30.02% | -21.89% | -23.16% |
| Return on Capital Employed (ROCE) | -102.10% | -61.20% | -65.10% | -41.40% | -43.40% | -31.00% |
| Earnings Yield | -7.70% | -7.90% | -10.53% | -17.98% | -32.73% | -13.78% |
| FCF Yield | -6.24% | -7.02% | -9.52% | -17.40% | -27.74% | -12.45% |
| Buyback Yield / Dilution | -22.41% | -16.28% | -24.07% | -23.16% | -27.29% | -32.48% |